Comparison

IL-2, Human  European Partner

Item no. Z00368-1
Manufacturer GenScript
Amount 1 mg
Category
Type Proteins
Specific against Human
Purity Greater than 98% as determined by the following methods: (a) SEC-HPLC analysis (b) Reducing and non-reducing SDS-PAGE silver-stained gel analysis
Citations Yu J, et al . Interleukin-2 reconstitutes defective human immunodeficiency virus (HIV), and cytomegalovirus (CMV) specific CD8+ T cell proliferation in HIV infection. J. Med. Virol. Sep 2006, 78 (9): 1147-1157. Perchonock CE, et al . Negative Regulation of Interleukin-2 and p38 Mitogen-Activated Protein Kinase during T-Cell Activation by the Adaptor ALX. Mol. Cell. Biol. Aug 2006, 26 (16): 6005-6015. Gujar SA, Michalak TI. Characterization of bioactive recombinant woodchuck interleukin-2 amplified by RLM-RACE and produced in eukaryotic expression system. Vet. Immunol. Immunopathol. Aug 2006, 112 (3-4): 183-198.
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias In vitro, studies performed on human cell lines demonstrate the immunoregulatory properties of Interleukin-2 (IL-2) including: 1) enhancement of lymphocyte mitogenesis and stimulation of long-term growth of human Interleukin-2 (IL-2) dependent edll lines, 2) enhancement of lymphocyte cytotoxicity, 3) induction of killer cell (lymphokine-activated (LAK) and natural (NK)) activity, 4) induction of interferon-gamma production. Recombinant human Interleukin-2 (IL-2), is a highly purified protein with a molecular weight of approximately 15,300 Da. The chemical name is des-alanyl-1, serine-125 human interleukin-2. It is produced by recombinant DNA technology using a genetically engineered, E. coli, strain containing an analog of the human Human Interleukin-2 (IL-2) gene. Genetic engineering techniques were used to modify the human Interleukin-2 (IL-2) gene, and the resulting expression clone encodes a modified human Interleukin-2 (IL-2). This recombinant form differs from native Interleukin-2 (IL-2) in following ways: 1) it is not glycosylated, 2) the molecule has no N-terminal alanine, 3) the molecule has serine substituted for cysteine at amino acid position 125, 4) the aggregation state of molecule is likely to be different from that of native Interleukin-2 (IL-2).</td></tr><tr><th>M.W.</th><td colspan="7"> 15,300 Da</td></tr><tr><th>Purity</th><td colspan="7"> Greater than 98% as determined by the following methods: (a) SEC-HPLC analysis (b) Reducing and non-reducing SDS-PAGE silver-stained gel analysis</td></tr><tr><th>Endotoxin Level</th><td colspan="7"> Less than 0.1 ng/ug (1 EU/ug) of recombinant human Interleukin-2 (IL-2) as determined by LAL test.</td></tr><tr><th>Specific Activity</th><td colspan="7"> The specific activity as determined and was found to be greater than 1.0×107 IU/mg.</td></tr><tr><th>Storage</th><td colspan="7"> Lyophilized, recombinant human Interleukin-2 (IL-2), remains stable at room temperature for three weeks, but it is best stored desiccated below -18C. Upon reconstitution recombinant human Interleukin-2 (IL-2) should be stored at 4C for up to seven days. For long term storage it is recommended that a carrier protein (0.1% HSA or BSA) be added. Avoid repeated freeze-thaw cycles.</td></tr><tr><th>Formulation</th><td colspan="7"> The protein was lyophilized after extensive dialysis against 50mM Phosphate buffer, pH7.5, 5% Mannitol buffer.</td></tr><tr><th>Reconstitution</th><td colspan="7"> It is recommended to reconstitute the lyophilized recombinant human Interleukin-2 (IL-2) in sterile 18 Momega-cm H2O not less than 100 ug/ml, which can then be further diluted to other aqueous solutions.</td></tr><tr><th>Reference</th><td colspan="7">Yu J, et al . Interleukin-2 reconstitutes defective human immunodeficiency virus (HIV), and cytomegalovirus (CMV) specific CD8+ T cell proliferation in HIV infection. J. Med. Virol. Sep 2006, 78 (9): 1147-1157. Perchonock CE, et al . Negative Regulation of Interleukin-2 and p38 Mitogen-Activated Protein Kinase during T-Cell Activation by the Adaptor ALX. Mol. Cell. Biol. Aug 2006, 26 (16): 6005-6015. Gujar SA, Michalak TI. Characterization of bioactive recombinant woodchuck interleukin-2 amplified by RLM-RACE and produced in eukaryotic expression system. Vet. Immunol. Immunopathol. Aug 2006, 112 (3-4): 183-198.</td></tr>
Similar products Interleukin-2
Available
Specificity The specific activity as determined and was found to be greater than 1.0x107 IU/mg.
Specificity
The specific activity as determined and was found to be greater than 1.0x107 IU/mg.
Description
In vitro, studies performed on human cell lines demonstrate the immunoregulatory properties of Interleukin-2 (IL-2) including: 1) enhancement of lymphocyte mitogenesis and stimulation of long-term growth of human Interleukin-2 (IL-2) dependent edll lines, 2) enhancement of lymphocyte cytotoxicity, 3) induction of killer cell (lymphokine-activated (LAK) and natural (NK)) activity, 4) induction of interferon-gamma production. Recombinant human Interleukin-2 (IL-2), is a highly purified protein with a molecular weight of approximately 15, 300 Da. The chemical name is des-alanyl-1, serine-125 human interleukin-2. It is produced by recombinant DNA technology using a genetically engineered, E. coli, strain containing an analog of the human Human Interleukin-2 (IL-2) gene. Genetic engineering techniques were used to modify the human Interleukin-2 (IL-2) gene, and the resulting expression clone encodes a modified human Interleukin-2 (IL-2). This recombinant form differs from native Interleukin-2 (IL-2) in following ways: 1) it is not glycosylated, 2) the molecule has no N-terminal alanine, 3) the molecule has serine substituted for cysteine at amino acid position 125, 4) the aggregation state of molecule is likely to be different from that of native Interleukin-2 (IL-2).
Endotoxin Level
Less than 0.1 ng/ug (1 EU/ug) of recombinant human Interleukin-2 (IL-2) as determined by LAL test.
Formulation
The protein was lyophilized after extensive dialysis against 50mM Phosphate buffer, pH7.5, 5% Mannitol buffer.
M.W.
15, 300 Da
Product Line
Cytokine, Chemokines & Growth Factors
Reconstitution
It is recommended to reconstitute the lyophilized recombinant human Interleukin-2 (IL-2) in sterile 18 Momega-cm H2O not less than 100 ug/ml, which can then be further diluted to other aqueous solutions.
Storage
Lyophilized, recombinant human Interleukin-2 (IL-2), remains stable at room temperature for three weeks, but it is best stored desiccated below -18C. Upon reconstitution recombinant human Interleukin-2 (IL-2) should be stored at 4C for up to seven days. For long term storage it is recommended that a carrier protein (0.1% HSA or BSA) be added. Avoid repeated freeze-thaw cycles.
Manufacturers Category
Proteins
Manufacturers Product Line
Cytokines
Product Origin
USA

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close